Literature DB >> 8513808

Functional reconstitution of the Trypanosoma brucei plasma-membrane D-glucose transporter.

A Seyfang1, M Duszenko.   

Abstract

The D-glucose transporter of Trypanosoma brucei was solubilized from the plasma membrane and reconstituted into proteoliposomes. Using the reconstitution of D-glucose transport as the assay and non-specific L-glucose uptake as control, we have purified a membrane protein fraction from T. brucei bloodstream-form ghosts by EDTA/alkali treatment and solubilization with the detergents octylglucoside or octylthioglucoside. Upon removal of the detergent by dialysis, the solubilized protein fraction was reconstituted in sonicated liposomes by a freeze/thaw-sonication step. The reconstituted transporter catalyzed specific D-glucose uptake and was compared in several characteristics with the native facilitated-diffusion transporter as present in live trypanosomes [Seyfang, A. & Duszenko, M. (1991) Eur. J. Biochem. 202, 191-196]. As in vivo, the uptake is time dependent and Na+ independent. Transporter substrate affinity and inhibitor specificity are completely retained and it is inhibited by mercuric ions, phloretin and cytochalasin B, but only partially inhibited by phlorizin. The reconstituted transporter also demonstrates trans-stimulation properties indicative of the carrier-mediated transport of D-glucose. In contrast to the human erythrocyte-type glucose transporter, in T. brucei D-fructose uptake was also catalyzed by the same reconstituted protein fraction and specific D-glucose or D-fructose transport were mutually competitive. Both the inhibitor studies and the fructose transport capacity in the reconstituted system are in good agreement with the native transport in live trypanosomes. The specific activity of D-glucose transport was 1.9 +/- 0.3 nmol.min-1.mg protein-1 at 0.2 mM D-glucose and the yield was about 0.8% of total ghost protein after removal of the variant-surface-glycoprotein coat. The successful functional reconstitution of a protozoan glucose transporter represents an important step towards its purification and detailed characterization. This is especially interesting since bloodstream-form trypanosomes depend entirely upon glycolysis for their ATP production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513808     DOI: 10.1111/j.1432-1033.1993.tb17958.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

Review 1.  Kinetoplastid glucose transporters.

Authors:  E Tetaud; M P Barrett; F Bringaud; T Baltz
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei.

Authors:  B M Bakker; H V Westerhoff; P A Michels
Journal:  J Bioenerg Biomembr       Date:  1995-10       Impact factor: 2.945

3.  Organization of two invariant surface glycoproteins in the surface coat of Trypanosoma brucei.

Authors:  K Ziegelbauer; P Overath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

4.  Gluconeogenesis using glycerol as a substrate in bloodstream-form Trypanosoma brucei.

Authors:  Julie Kovářová; Rupa Nagar; Joana Faria; Michael A J Ferguson; Michael P Barrett; David Horn
Journal:  PLoS Pathog       Date:  2018-12-27       Impact factor: 6.823

5.  Murine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropism.

Authors:  Christiane Giroud; Florence Ottones; Virginie Coustou; Denis Dacheux; Nicolas Biteau; Benjamin Miezan; Nick Van Reet; Mark Carrington; Felix Doua; Théo Baltz
Journal:  PLoS Negl Trop Dis       Date:  2009-09-01

6.  Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.

Authors:  Julie Kovářová; Andrew W Pountain; David Wildridge; Stefan Weidt; Frédéric Bringaud; Richard J S Burchmore; Fiona Achcar; Michael P Barrett
Journal:  PLoS Pathog       Date:  2018-03-19       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.